Abciximab | Interleukin Related interleukin-related.com

Product Name :
Abciximab

Search keywords :
Abciximab

drugId :
null

Target Vo:
Integrin alpha-IIb/beta-3

Target Vo Short Name :
GP IIb/IIIa

Moa_Name:
Integrin alpha-IIb/beta-3 antagonists

First Approval Country :
United States

First Approval Date Filter:
1994

Origin Company_Name :
Johnson & Johnson Innovative Medicine

Active Company_Name :
Janssen Biotech Inc

Active Indication_Name:
Myocardial Ischemia

In Active Indication_Name:
ST Elevation Myocardial Infarction

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
FOXA2 Antibody
Phospho-ERK1/2 (Tyr204/Tyr187) Antibody
Ubiquitin-like modifier-activating enzyme 1 Antibody: Ubiquitin-like modifier-activating enzyme 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 118 kDa, targeting to Ubiquitin-like modifier-activating enzyme 1. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts